Med journals adopt disclosure rules

Editors at leading medical journals have linkurl:agreed;http://www.icmje.org/format.pdf to adopt a new standard conflict of interest disclosure form that probes deep into the financial and nonfinancial interests of published authors. __The Lancet__, __The Journal of the American Medical Association__, __The New England Journal of Medicine__, and __The British Medical Journal__, among other medical journals, will be phasing in the more rigorous requirements over the next couple of months, accordi

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Editors at leading medical journals have linkurl:agreed;http://www.icmje.org/format.pdf to adopt a new standard conflict of interest disclosure form that probes deep into the financial and nonfinancial interests of published authors. __The Lancet__, __The Journal of the American Medical Association__, __The New England Journal of Medicine__, and __The British Medical Journal__, among other medical journals, will be phasing in the more rigorous requirements over the next couple of months, according to linkurl:__The Wall Street Journal__.;http://online.wsj.com/article/SB125547553843083589.html?mod=dist_smartbrief The disclosure linkurl:form,;http://www.icmje.org/coi_disclosure.pdf which was drafted by the International Committee of Medical Journal Editors (ICMJE), prompts authors for information regarding financial relationships -- such as board membership, consultancy, expert testimony, honoraria and stock options -- and potentially conflicting financial relationships among spouses and children under age 18. Authors are asked to submit financial disclosures for arrangements stretching back up to three years prior to the submission of a manuscript. The form also asks for information regarding "relevant nonfinancial associations," such as political, personal, institutional, or religious affiliations that "a reasonable reader would want to know about in relation to the submitted work." The move follows increasing calls for medical journals to standardize their conflict disclosure policies. Last summer, the Center for Science in the Public Interest (CSPI) unveiled disclosure guidelines that closely parallel the rules set forth by the ICMJE. linkurl:Merrill Goozner,;http://www.gooznews.com/ former director of the CSPI's Integrity in Science project and lead author on that organization's disclosure guidelines, told __The Scientist__ that the ICMJE's rules are welcome, if not overdue. "We feel like our work set the stage for what the ICMJE came out with yesterday," he said. "We helped plant the idea that this is the proper thing to do. We're very glad they did it." Regarding the disclosure of nonfinancial conflicts, such as political or religious affiliations, Goozner noted that the disclosure is between author and editors. "There's obviously room for discretion on the part of the editor as far as what gets published," he said. "I think that's the right thing to do." The ICMJE's new disclosure guidelines apply only to authors, not peer reviewers or editors. Goozner suggested that this is a shortcoming in the new rules. "This is something editors need to know so they can discriminate among who they ask to conduct peer review," he said.
**__Related stories:__***linkurl:Unifying journal disclosure rules;http://www.the-scientist.com/blog/display/54836/
[17th July 2008]*linkurl:Promoting Integrity in Science Journals;http://www.the-scientist.com/article/display/38023/
[January 2007]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo
Sapio Sciences logo

Sapio Sciences Introduces Biorepository Management Solution